{"id":5699,"date":"2022-09-28T07:30:21","date_gmt":"2022-09-28T06:30:21","guid":{"rendered":"https:\/\/core-attorneys.com\/?p=5699"},"modified":"2022-09-28T10:35:21","modified_gmt":"2022-09-28T09:35:21","slug":"weko-eroeffnung-einer-untersuchung-gegen-novartis","status":"publish","type":"post","link":"https:\/\/core-attorneys.com\/en\/news-insights\/weko-eroeffnung-einer-untersuchung-gegen-novartis\/","title":{"rendered":"COMCO: Opening of an Investigation against Novartis"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"5699\" class=\"elementor elementor-5699\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"has_eae_slider elementor-section elementor-top-section elementor-element elementor-element-5e192929 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-eae-slider=\"95519\" data-id=\"5e192929\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"has_eae_slider elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-328c9e8\" data-eae-slider=\"56508\" data-id=\"328c9e8\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-1457845 elementor-widget elementor-widget-image\" data-id=\"1457845\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"825\" height=\"495\" src=\"https:\/\/core-attorneys.com\/wordpress\/wp-content\/uploads\/2022\/09\/20220927-WEKO-Eroeffnung-einer-Untersuchung-gegen-Novartis.jpg\" class=\"attachment-full size-full wp-image-5702\" alt=\"WEKO: Er\u00f6ffnung einer Untersuchung gegen Novartis\" srcset=\"https:\/\/core-attorneys.com\/wordpress\/wp-content\/uploads\/2022\/09\/20220927-WEKO-Eroeffnung-einer-Untersuchung-gegen-Novartis.jpg 825w, https:\/\/core-attorneys.com\/wordpress\/wp-content\/uploads\/2022\/09\/20220927-WEKO-Eroeffnung-einer-Untersuchung-gegen-Novartis-300x180.jpg 300w, https:\/\/core-attorneys.com\/wordpress\/wp-content\/uploads\/2022\/09\/20220927-WEKO-Eroeffnung-einer-Untersuchung-gegen-Novartis-768x461.jpg 768w, https:\/\/core-attorneys.com\/wordpress\/wp-content\/uploads\/2022\/09\/20220927-WEKO-Eroeffnung-einer-Untersuchung-gegen-Novartis-18x12.jpg 18w\" sizes=\"(max-width: 825px) 100vw, 825px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"has_eae_slider elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-a76e28a\" data-eae-slider=\"34290\" data-id=\"a76e28a\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-99081b4 elementor-widget elementor-widget-theme-post-title elementor-page-title elementor-widget-heading\" data-id=\"99081b4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"theme-post-title.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">WEKO: Er\u00f6ffnung einer Untersuchung gegen Novartis<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5f29e2b elementor-widget elementor-widget-post-info\" data-id=\"5f29e2b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"post-info.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<ul class=\"elementor-inline-items elementor-icon-list-items elementor-post-info\">\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item elementor-repeater-item-685ec73 elementor-inline-item\" itemprop=\"about\">\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-tags\"><\/i>\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text elementor-post-info__item elementor-post-info__item--type-terms\">\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-post-info__terms-list\">\n\t\t\t\t<span class=\"elementor-post-info__terms-list-item\">Competition<\/span>, <span class=\"elementor-post-info__terms-list-item\">News<\/span>\t\t\t\t<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t<li class=\"elementor-icon-list-item elementor-repeater-item-d50ae70 elementor-inline-item\" itemprop=\"datePublished\">\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-calendar\"><\/i>\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text elementor-post-info__item elementor-post-info__item--type-date\">\n\t\t\t\t\t\t\t\t\t\t<time>28.09.2022<\/time>\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t<li class=\"elementor-icon-list-item elementor-repeater-item-ec6c601 elementor-inline-item\">\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-user-circle\"><\/i>\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text elementor-post-info__item elementor-post-info__item--type-custom\">\n\t\t\t\t\t\t\t\t\t\tMario Strebel, Fabian Koch\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4d17332b elementor-widget elementor-widget-text-editor\" data-id=\"4d17332b\" data-element_type=\"widget\" data-e-type=\"widget\" data-no-translation=\"\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<style>.elementor-element-4d17332b{display:none !important}<\/style>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e6fdab6 elementor-widget elementor-widget-text-editor\" data-id=\"e6fdab6\" data-element_type=\"widget\" data-e-type=\"widget\" data-no-translation=\"\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<style>.elementor-element-e6fdab6{display:none !important}<\/style>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0bcb7c3 elementor-widget elementor-widget-text-editor\" data-id=\"0bcb7c3\" data-element_type=\"widget\" data-e-type=\"widget\" data-no-translation=\"\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>The Competition Commission (COMCO) opened an investigation against the Swiss pharmaceutical company Novartis and conducted a dawn raid at its headquarters in Basel on 13 September 2022.<\/strong><\/p><p>According to its press release, Novartis is suspected of having abusively asserted a patent in court and thus abusing a dominant market position (blocking patent). Specifically, the pharmaceutical company shall allegedly have tried to protect its own preparation for the treatment of skin diseases by initiating legal proceedings against competing products on the basis of an own patent. According to the COMCO, this could constitute an abuse of a dominant position pursuant to the Swiss Cartel Act.<\/p><p>In this context, the investigation by the COMCO is supposed to clarify whether Novartis has in fact been using blocking patents in an abusive manner. The presumption of innocence applies<\/p><p>With regard to the investigation, the COMCO is cooperating with the European Commission on the basis of the bilateral agreement between Switzerland and the European Union (EU) concerning cooperation on the application of their competition laws from 2014. In the EU, the unlawful use of patents or patent proceedings has already been dealt with in various cases, for example in the much-noticed decision in the matter <a href=\"https:\/\/curia.europa.eu\/juris\/document\/document.jsf;jsessionid=542009F81ACF544FA638318221C3877C?text=&amp;docid=82135&amp;pageIndex=0&amp;doclang=EN&amp;mode=lst&amp;dir=&amp;occ=first&amp;part=1&amp;cid=1374588\" target=\"_blank\" rel=\"noopener\"><em>AstraZeneca\/Commission<\/em><\/a> (judgment of the ECJ of 1 July 2010 in case T\u2011321\/05, [2010] ECR II-2805 2010 II\u20112805, para. 361 ff., <em>AstraZeneca\/Commission<\/em>) or in the <a href=\"https:\/\/ec.europa.eu\/competition\/elojade\/isef\/case_details.cfm?proc_code=1_AT_39246\" target=\"_blank\" rel=\"noopener\"><em>Boehringer<\/em><\/a> case (case closed by the European Commission in Case COMP\/39246 &#8211; AT.39246 <em>Boehringer<\/em> after settlement of the dispute between the parties). This is in contrast to Switzerland, where the present proceeding is, as far as can be seen, the first of its kind.<\/p><p>The COMCO press release on the opening of the investigation can be found <a href=\"https:\/\/www.weko.admin.ch\/weko\/en\/home\/medien\/press-releases\/nsb-news.msg-id-90320.html\" target=\"_blank\" rel=\"noopener\">here<\/a>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c0b3fb0 elementor-widget elementor-widget-text-editor\" data-id=\"c0b3fb0\" data-element_type=\"widget\" data-e-type=\"widget\" data-no-translation=\"\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>CORE Attorneys is a boutique law firm in Switzerland, focusing on <a href=\"https:\/\/core-attorneys.com\/en\/expertise\/wettbewerbsrecht\/\">competition\/antitrust law<\/a>, <a href=\"https:\/\/core-attorneys.com\/en\/expertise\/regulierung\/\">regulatory<\/a> and <a href=\"https:\/\/core-attorneys.com\/en\/expertise\/vertriebsrecht\/\">distribution law<\/a> matters. Visit our <a href=\"https:\/\/core-attorneys.com\/en\/news-insights\/\">News &amp; Insights<\/a> and follow us on <a href=\"https:\/\/www.linkedin.com\/company\/core-attorneys\">LinkedIn<\/a> for regular updates on all our focus areas.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Die Wettbewerbskommission (WEKO) hat am 13. September 2022 eine Untersuchung gegen das schweizerische Pharmaunternehmen Novartis er\u00f6ffnet und in dessen Hauptsitz in Basel eine Hausdurchsuchung durchgef\u00fchrt. Gem\u00e4ss Pressemitteilung wird Novartis verd\u00e4chtigt, ein Patent missbr\u00e4uchlich vor Gericht geltend gemacht und damit eine&#8230;<\/p>","protected":false},"author":1,"featured_media":5702,"comment_status":"open","ping_status":"open","sticky":false,"template":"elementor_header_footer","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_seopress_titles_title":"WEKO: Er\u00f6ffnung einer Untersuchung gegen Novartis","_seopress_titles_desc":"Novartis, Kartellgesetz, Kartellrecht, Schweiz, WEKO, Wettbewerbskommission, KG, Patent, Patentverwendung, blocking-patent, Sperrpatent, Missbrauch, Marktbeherrschung, marktbeherrschende Stellung, Marktmachtmissbrauch, Untersuchung, Europ\u00e4ische Kommission, bilaterales Abkommen, EU, Europ\u00e4ische Union, AstraZeneca, Rechtssache T\u2011321\/05, Boehringer, COMP\/39246, ","_seopress_robots_index":"","footnotes":""},"categories":[10,9],"tags":[322,320,317,324,325,42,149,321,105,56,106,82,80,79,81,314,315,316,323,74,318,319,39,110],"class_list":["post-5699","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-competition","category-neuigkeiten","tag-astrazeneca","tag-bilaterales-abkommen","tag-blocking-patent","tag-boehringer","tag-comp-39246","tag-eu","tag-europaeische-kommission","tag-europaeische-union","tag-kartellgesetz","tag-kartellrecht","tag-kg","tag-marktbeherrschende-stellung","tag-marktbeherrschung","tag-marktmachtmissbrauch","tag-missbrauch","tag-novartis","tag-patent","tag-patentverwendung","tag-rechtssache-t321-05","tag-schweiz","tag-sperrpatent","tag-untersuchung","tag-weko","tag-wettbewerbskommission"],"_links":{"self":[{"href":"https:\/\/core-attorneys.com\/en\/wp-json\/wp\/v2\/posts\/5699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/core-attorneys.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/core-attorneys.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/core-attorneys.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/core-attorneys.com\/en\/wp-json\/wp\/v2\/comments?post=5699"}],"version-history":[{"count":26,"href":"https:\/\/core-attorneys.com\/en\/wp-json\/wp\/v2\/posts\/5699\/revisions"}],"predecessor-version":[{"id":5727,"href":"https:\/\/core-attorneys.com\/en\/wp-json\/wp\/v2\/posts\/5699\/revisions\/5727"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/core-attorneys.com\/en\/wp-json\/wp\/v2\/media\/5702"}],"wp:attachment":[{"href":"https:\/\/core-attorneys.com\/en\/wp-json\/wp\/v2\/media?parent=5699"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/core-attorneys.com\/en\/wp-json\/wp\/v2\/categories?post=5699"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/core-attorneys.com\/en\/wp-json\/wp\/v2\/tags?post=5699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}